Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's NDA And BLA Approvals: Kymriah, Vabomere, Cyltezo

Sep 01 2017

Related Content

Proceeds From Chagas Treatment Priority Review Voucher Will Help Ensure Access

Aug 31 2017

Novartis CAR-T Therapy's Swift Approval Aided By REMS And New US FDA Review Model

Aug 31 2017

Humira Biosimilar: Boehringer Faces Same Launch Hurdles As Amgen

Aug 28 2017

Additional Topics

United States Approvals ImmunoOncology Regulation Cancer Infectious Diseases BioPharmaceutical Inflammation

More from Approvals

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window